Experimental Diabetes Causes Breakdown of the Blood-Retina Barrier by a Mechanism Involving Tyrosine Nitration and Increases in Expression of Vascular Endothelial Growth Factor and Urokinase Plasminogen Activator Receptor-Reference-Cited by-同舟云学术

Experimental Diabetes Causes Breakdown of the Blood-Retina Barrier by a Mechanism Involving Tyrosine Nitration and Increases in Expression of Vascular Endothelial Growth Factor and Urokinase Plasminogen Activator Receptor

Published:2003-06 Issue:6 Volume:162 Page:1995-2004
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

El-Remessy Azza B.,Behzadian M. Ali,Abou-Mohamed Gamal,Franklin Telina,Caldwell Robert W.,Caldwell Ruth B.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference58 articles.

1. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content;Antonetti;Diabetes,1998

2. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy;Adamis;Am J Ophthalmol,1994

3. VEGF-initiated blood-retinal barrier breakdown in early diabetes;Qaum;Invest Ophthalmol Vis Sci,2001

4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N Engl J Med,1994

5. Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats;Takeda;Diabetologia,2001

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Glucose Increases Lactate and Induces the Transforming Growth Factor Beta-Smad 1/5 Atherogenic Pathway in Primary Human Macrophages;Biomedicines;2024-07-16

2. Effects of Nox4 upregulation on PECAM-1 expression in a mouse model of diabetic retinopathy;PLOS ONE;2024-05-15

3. Investigation of the Effects of a Novel NOX2 Inhibitor, GLX7013170, against Glutamate Excitotoxicity and Diabetes Insults in the Retina;Pharmaceuticals;2024-03-19

5. Captopril alleviates oxidative damage in diabetic retinopathy;Life Sciences;2022-02